Grace Therapeutics, Inc. (GRCE)
NASDAQ: GRCE · Real-Time Price · USD
3.290
-0.100 (-2.95%)
Feb 21, 2025, 4:00 PM EST - Market closed

Grace Therapeutics Statistics

Total Valuation

GRCE has a market cap or net worth of $33.36 million. The enterprise value is $22.31 million.

Market Cap 33.36M
Enterprise Value 22.31M

Important Dates

The last earnings date was Thursday, February 13, 2025, before market open.

Earnings Date Feb 13, 2025
Ex-Dividend Date n/a

Share Statistics

GRCE has 10.14 million shares outstanding. The number of shares has increased by 34.86% in one year.

Current Share Class 10.14M
Shares Outstanding 10.14M
Shares Change (YoY) +34.86%
Shares Change (QoQ) n/a
Owned by Insiders (%) 25.22%
Owned by Institutions (%) 7.85%
Float 5.23M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.64
P/TBV Ratio 11.61
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 6.06

Current Ratio 6.06
Quick Ratio 5.76
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -22.89% and return on invested capital (ROIC) is -17.83%.

Return on Equity (ROE) -22.89%
Return on Assets (ROA) -15.16%
Return on Invested Capital (ROIC) -17.83%
Return on Capital Employed (ROCE) -28.13%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax -3.07M
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) 1.37
52-Week Price Change n/a
50-Day Moving Average 3.67
200-Day Moving Average n/a
Relative Strength Index (RSI) 42.89
Average Volume (20 Days) 129,921

Short Selling Information

The latest short interest is 36,204, so 0.36% of the outstanding shares have been sold short.

Short Interest 36,204
Short Previous Month 38,148
Short % of Shares Out 0.36%
Short % of Float 0.69%
Short Ratio (days to cover) 0.42

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -16.67M
Pretax Income n/a
Net Income -13.37M
EBITDA -16.66M
EBIT -16.67M
Earnings Per Share (EPS) -$1.16
Full Income Statement

Balance Sheet

Cash & Cash Equivalents 11.06M
Total Debt n/a
Net Cash 11.06M
Net Cash Per Share $1.09
Equity (Book Value) 52.14M
Book Value Per Share 5.14
Working Capital 9.97M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$14.04 million and capital expenditures -$22,000, giving a free cash flow of -$14.06 million.

Operating Cash Flow -14.04M
Capital Expenditures -22,000
Free Cash Flow -14.06M
FCF Per Share -$1.39
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

GRCE does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -34.86%
Shareholder Yield -34.86%
Earnings Yield -40.08%
FCF Yield -42.15%

Analyst Forecast

The average price target for GRCE is $12.00, which is 264.74% higher than the current price. The consensus rating is "Strong Buy".

Price Target $12.00
Price Target Difference 264.74%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) -10.27%
Stock Forecasts

Stock Splits

The last stock split was on July 10, 2023. It was a reverse split with a ratio of 0.1666667:1.

Last Split Date Jul 10, 2023
Split Type Reverse
Split Ratio 0.1666667:1

Scores

Altman Z-Score n/a
Piotroski F-Score n/a